Cellular adjustment of gastric cancer for hepatic metastasis in successive orthotopic implantation model

Cancer Biology and Therapy

Volumn 5, Issue 10, 2006, Pages 1313-1319

  Shen, XiongHu ^a,b,d   Jin, WuNan ^d   Cui, Hai ^d   Cui, Xian ^d   Noh, SungHoon ^a,b   Chung, HyunCheol ^a,b,c   Lin, ZhenHua ^d,e  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d YANBIAN UNIVERSITY   (China)

^e BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Cancer; Gastric; Implantation; Liver metastasis; Orthotopic; Phenotype

Indexed keywords

DYSTROGLYCAN; PROTEIN DAG1; PROTEIN PRECURSOR; PROTEIN SIL1; UNCLASSIFIED DRUG; UVOMORULIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL STRUCTURE; CONTROLLED STUDY; CYTOGENETICS; GENE EXPRESSION; IMPLANTATION; LIVER METASTASIS; MOLECULAR CLONING; NONHUMAN; PHENOTYPE; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER;

EID: 33751117985     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.5.10.3157     Document Type: Article

References (28)

1. Douglas H, Robert AW. The hallmarks of cancer. Cell 2000; 100:57-70.
2. Kwok CM, Wu CW, Lo SS, Shen KH, Hsieh MC, Lui WY. Survival of gastric cancer with concomitant liver metastases. Hepatogastroenterology 2004; 51:1527-30.
3. Zetter BR. The Cellular basis of site-specific tumor metastasis. N Engl J Med 1990; 322:605-12.
4. Woodhouse EC, Chuaqui RF, Liotta LA. General mechanisms of metastasis. Cancer 1997; 80:1529-37.
5. Peter H, Stephan G. Gastric cancer. Lancet 2003; 362:305-15.
6. Fidler IJ. The pathogenesis of cancer metastasis: the "seed and soil" hypothesis revisited. Nat Rev Cancer 2003; 3:453-8.
7. Fidler IJ. naito S, Pathak S. Orthotopic implantation is essential for the selection, growth and metastasis of human renal cancer cell in nude mice. Cancer Metastasis Rev 1990; 9:149-65.
8. Pettaway CA, Pathak S, Greene G, Ramirez E, Wilson MR, Killion JJ, Fidler IJ. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Clin Cancer Res 1996; 2:1627-36.
9. Fidler IJ. Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res 1978; 38:2651-60.
10. Li Y, Tang ZY, Ye SL, Liu YK, Chen J, Xue Q, Chen J, Gao DM, Bao WH. Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. World J Gastroenterol 2001; 7:630-6.
11. Hippo Y, Yashiro M, Ishii M, Taniguchi H, Tsutsumi S, Hirakawa K, Kodama T, Aburatani H. Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res 2001; 61:889-95.
12. Wellstein A, Lupu R, Zugmaier G. Autocrine growth stimulation by secreted Koposi's fibroblast growth factor but not by endogenous basic fibroblast growth factor. Growth Diff 1990; 1:63-71.
13. Frandsen TL, Boysen BE, Jirus S. Assay for the study of human cancer cell invasion and metastasis. Fibrinolysis 1992; 6(suppl):71-6.
14. Shi YE, Torri J, Yieh L, Wellstein A, Lippman ME, Dickson RB. Identification and characterization of a novel matrix-degrading protease from hormone-dependent human cancer cells. Cancer Res 1993; 53:1409-15.
15. Kleiner DE, Stetler-Stevenson WG. Quantitative zymography; Detection of picogram quantities of gelatinases. Anal Biochem 1994; 218:325-9.
16. Kim B, Bang S, Lee S, Kim S, Jung Y, Lee C, Choi K, Lee SG, Lee K, Lee Y, Kim SS, Yeom YI, Kim YS, Yoo HS, Song K, Lee I. Expression profiling and subtype-specific expression of stomach cancer. Cancer Res 2003; 63:8248-55.
17. Glinskii AB, Smith BA, Jiang P, Li XM, Yang M, Hoffman RM, Glinsky GV. Viable circulating metastatic cells produced in orthotopic but not ectopic prostate cancer models. Cancer Res 2003; 63:4239-43.
18. Yamamoto N, Yang M, Jiang P, Xu M, Tsuchiya H, Tomita K, Moossa AR, Hoffman RM. Determination of Clonality of Metastasis by Cell-Specific Color-Coded Fluorescent-Protein Imaging. Cancer Res 2003; 63:7785-90.
19. Swartz MA, Kristensen CA, Melder RJ, Roberge S, Calautti E, Fukumura D, Jain RK. Cells shed from tumours show reduced clonogenecity, resistance to apoptosis, and in vivo tumorigenicity. Brit J Cancer 1999; 81:756-9.
20. Tester AM, Waltham M, Oh SJ, Bae SN, Bills MM, Walker EC, Kern FG, Stetler-Stevenson WG, Lippman ME, Thompson EW. Pro-matrix metalloproteinase-2 transfection increases orthotopic primary growth and experimental metastasis of MDA-MB-231 Human breast cancer cells in nude mice. Cancer Res 2004; 64:652-8.
21. Zeng ZS, Huang Y, Cohen AM, Guilem JG. Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9. J Clin Oncol 1996; 14:3133-40.
22. Hibbs MS. Expression of 92 kDa phagocyte gelatinase by inflammatory and connective tissue cells. Matrix Suppl 1992;1:51-7.
23. Baba H, Korenaga D, Kakeji Y, Haraguchi M, Okamura T, Maehara Y. DNA ploidy and its clinical implications in gastric cancer. Surgery 2002; 131:363-70.
24. Fidler IJ and Kripke ML. Genomic analysis of primary tumors does not address the prevalence of metastatic cells in the population. Nature 2003; 34:23.
25. Steven JW. The complexities of dystroglycan. Trends Biochem Sci 2001; 26:118-24.
26. Sgambato A, Migaldi M, Montanari M, Camerini A, Brancaccio A, Rossi G, Cangiano R, Losasso C, capelli G, Trentini GP, Cittadini A. Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression. Am J Pathol 2003; 162:849-60.
27. Daniel EM, Kevin PC. Dystrophin-glycoprotein complex: Post-translational processing and dystroglycan function. J Biol Chem 2003; 278:15457-60.
28. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C, Guise TA, Massague J. A multigenic program mediating breast cancer metastasis to bone. Cancer cell 2003; 3:537-49.